FDA Clearance Tracker · P160017-S125
MiniMed 780G System
Last checked: Nov 20, 2026Latest source record: Dec 11, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Dec 11, 2025
Approved
Time to decision
225 days
Received Apr 30, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P160017-S125
- Device name
- MiniMed 780G System
- Applicant
- Medtronic Minimed, Inc.
- Applicant location
- Northridge, CA
- Received
- Apr 30, 2025
- Decided
- Dec 11, 2025
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P160017
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval of expanding the compatible insulins for use with the MiniMed 780G system to include Fiasp and Lyumjev.
Source documents
Other decisions for Medtronic Minimed, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- MiniMed Flex pump510(k)
K253743 · Decided Mar 12, 2026 · 108 days after receipt
Device type: Alternate Controller Enabled Insulin Infusion Pump (QFG) · Laboratory Medicine & Pathology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.